Vaxart Inc Stock Price on December 19, 2024

VXRT Stock  USD 0.73  0.00  0.000003%   
Below is the normalized historical share price chart for Vaxart Inc extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vaxart stands at 0.73, as last reported on the 30th of December, with the highest price reaching 0.78 and the lowest price hitting 0.60 during the day.
IPO Date
12th of February 2018
200 Day MA
0.7883
50 Day MA
0.669
Beta
0.703
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Vaxart Stock, it is important to understand the factors that can impact its price. Vaxart Inc owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0169, which indicates the firm had a -0.0169% return per unit of risk over the last 3 months. Vaxart Inc exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vaxart's Coefficient Of Variation of (26,990), variance of 21.44, and Risk Adjusted Performance of 0.0053 to confirm the risk estimate we provide.
  
Vaxart Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0169

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsVXRT

Estimated Market Risk

 4.65
  actual daily
41
59% of assets are more volatile

Expected Return

 -0.08
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Vaxart is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vaxart by adding Vaxart to a well-diversified portfolio.
Price Book
2.429
Enterprise Value Ebitda
(0.17)
Price Sales
11.9358
Shares Float
211.1 M
Wall Street Target Price
4.8333

Vaxart Main Headline on 19th of December 2024

Filed transaction by Vaxart Inc Officer Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3

Vaxart Valuation on December 19, 2024

It is possible to determine the worth of Vaxart on a given historical date. On December 19, 2024 Vaxart was worth 0.58 at the beginning of the trading date compared to the closed value of 0.6. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vaxart stock. Still, in general, we apply an absolute valuation method to find Vaxart's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vaxart where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vaxart's related companies.
 Open High Low Close Volume
  0.58    0.60    0.54    0.54    2,296,062  
12/19/2024
  0.58    0.63    0.53    0.60    2,367,212  
  0.60    0.64    0.59    0.62    1,573,250  
Backtest Vaxart  |  Vaxart History  |  Vaxart Valuation   PreviousNext  
Open Value
0.58
0.6
Closing Value
14.52
Upside

Vaxart Trading Date Momentum on December 19, 2024

On December 20 2024 Vaxart Inc was traded for  0.62  at the closing time. The top price for the day was 0.64  and the lowest listed price was  0.59 . The trading volume for the day was 1.6 M. The trading history from December 20, 2024 was a factor to the next trading day price appreciation. The trading price change against the next closing price was 3.33% . The trading price change against the current closing price is 21.67% .

Vaxart Inc Fundamentals Correlations and Trends

By evaluating Vaxart's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vaxart's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vaxart financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Vaxart Stock history

Vaxart investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vaxart is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vaxart Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vaxart stock prices may prove useful in developing a viable investing in Vaxart
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company is headquartered in South San Francisco, California. Vaxart operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 110 people.

Vaxart Quarterly Net Working Capital

55.78 Million

Vaxart Stock Technical Analysis

Vaxart technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vaxart technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vaxart trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Vaxart Period Price Range

Low
December 30, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Vaxart Inc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Vaxart December 30, 2024 Market Strength

Market strength indicators help investors to evaluate how Vaxart stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vaxart shares will generate the highest return on investment. By undertsting and applying Vaxart stock market strength indicators, traders can identify Vaxart Inc entry and exit signals to maximize returns

Vaxart Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Vaxart's price direction in advance. Along with the technical and fundamental analysis of Vaxart Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vaxart to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.